Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Tolerability'
Tolerability published presentations and documents on DocSlides.
VIEWPOINT*EDITORIALSbefunded.3Theleast-costsystemhasfamilyphysiciansat
by cheryl-pisano
VIEWPOINT*EDITORIALSStudiesinquestionThefirstrepor...
Long-Term Tolerability of
by briana-ranney
Ticagrelor. for Secondary Prevention: . Insights...
The Safety and Tolerability of CSL112, a Reconstituted, Inf
by faustina-dinatale
A. poA. -I . E. vent reducin. G. in . I. schemic...
Evaluation of tolerability, pharmacokinetics, and anti-
by pamella-moone
r. etroviral activity of MK-8591 in treatment-na...
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
by pamella-moone
Hyperlipidemic. Subjects: A 52 Week Phase 3 Dou...
Safety , Tolerability, and Pharmacokinetics of Long-Acting Injectable
by phoebe-click
Cabotegravir. in Low-Risk . HIV-uninfected . Wom...
CAD/PAD in Primary Care CV Risk in Stable Outpatients
by stefany-barnette
Stratified by Baseline CV Risk Category. Aspirin ...
TES Safety and Tolerability
by breezeibm
Dr. Michael Amlung. 12/8/2017. Disclaimer. The con...
A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and
by warlikebikers
IMPAACT . 2001 STUDY . Mhembere T.P. (B. Pharm . (...
Objective To determine the safety and tolerability of self-instilled intravesicular probiotic
by rozelle
Lactobacillus . via intermittent catheterization f...
Long-term use and tolerability of
by verticalbikers
Irbesartan. . for control of . Hypertension. Vale...
Understanding Treatment Tolerability in Older Patients with
by tremblay
Advanced Cancer. Supriya Mohile, MD, MS. Philip an...
Pharmacokinetics, Safety and Tolerability of
by GirlNextDoor
Doravirine. in Adolescents with HIV-1. Brookie. ...
Alivelu M. Irrinki, M.Sc.
by TinyTeddy
Gilead Sciences. Foster City, CA , USA. Activating...
HallucinogenUseandMisuseinOlderAdultsWmMauriceReddenSaifUrRahmanPa
by carla
DivisionofGeriatricPsychiatry,DepartmentofPsychiat...
Abstract #323 : An open-label, dose escalation, Phase I/II study to assess safety, tolerability, im
by caitlin
J. Bennouna. 1. , A. Sibille. 2. , C. Debruyne. 3....
Load More...